Titre : Abcès épidural

Abcès épidural : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Abcès épidural : Questions médicales les plus fréquentes", "headline": "Abcès épidural : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Abcès épidural : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Abcès épidural" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infections des espaces méningés", "url": "https://questionsmedicales.fr/mesh/D020819", "about": { "@type": "MedicalCondition", "name": "Infections des espaces méningés", "code": { "@type": "MedicalCode", "code": "D020819", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.228.709" } } }, "about": { "@type": "MedicalCondition", "name": "Abcès épidural", "alternateName": "Epidural Abscess", "code": { "@type": "MedicalCode", "code": "D020802", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Joseph H Schwab", "url": "https://questionsmedicales.fr/author/Joseph%20H%20Schwab", "affiliation": { "@type": "Organization", "name": "From the Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA (Dr. Schwab), and the Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA (Dr. Shah)." } }, { "@type": "Person", "name": "Akash A Shah", "url": "https://questionsmedicales.fr/author/Akash%20A%20Shah", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Sandra B Nelson", "url": "https://questionsmedicales.fr/author/Sandra%20B%20Nelson", "affiliation": { "@type": "Organization", "name": "Department of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, USA, 02114." } }, { "@type": "Person", "name": "Aditya V Karhade", "url": "https://questionsmedicales.fr/author/Aditya%20V%20Karhade", "affiliation": { "@type": "Organization", "name": "Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA, 02114, USA; Harvard Combined Orthopaedic Residency Program, 55 Fruit Street, Boston, MA, USA, 02114." } }, { "@type": "Person", "name": "Joseph F Baker", "url": "https://questionsmedicales.fr/author/Joseph%20F%20Baker", "affiliation": { "@type": "Organization", "name": "University of Auckland, Auckland, Auckland, New Zealand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Impact of the national hepatitis B immunization program in China: a modeling study.", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36221140", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40249-022-01032-5" } }, { "@type": "ScholarlyArticle", "name": "Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.", "datePublished": "2024-06-10", "url": "https://questionsmedicales.fr/article/38857859", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2024.2357439" } }, { "@type": "ScholarlyArticle", "name": "Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36503856", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2022.11.074" } }, { "@type": "ScholarlyArticle", "name": "Investigation of non-National Immunization Program vaccination intentions in rural areas of China.", "datePublished": "2023-08-04", "url": "https://questionsmedicales.fr/article/37542236", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-023-16390-4" } }, { "@type": "ScholarlyArticle", "name": "Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.", "datePublished": "2023-10-31", "url": "https://questionsmedicales.fr/article/37956381", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3855/jidc.17886" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002493" }, { "@type": "ListItem", "position": 4, "name": "Infections du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002494" }, { "@type": "ListItem", "position": 5, "name": "Infections des espaces méningés", "item": "https://questionsmedicales.fr/mesh/D020819" }, { "@type": "ListItem", "position": 6, "name": "Abcès épidural", "item": "https://questionsmedicales.fr/mesh/D020802" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Abcès épidural - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Abcès épidural", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Abcès épidural", "description": "Comment diagnostique-t-on un abcès épidural ?\nQuels tests sanguins sont utiles ?\nQuels symptômes indiquent un abcès épidural ?\nL'IRM est-elle toujours nécessaire ?\nPeut-on diagnostiquer sans imagerie ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Immunization+Programs&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Abcès épidural", "description": "Quels sont les symptômes principaux ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes neurologiques ?\nComment la douleur se manifeste-t-elle ?\nPeut-on avoir des symptômes sans fièvre ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Immunization+Programs&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Abcès épidural", "description": "Comment prévenir un abcès épidural ?\nLes patients à risque doivent-ils être surveillés ?\nLes soins post-opératoires sont-ils importants ?\nLes vaccinations aident-elles à prévenir ?\nFaut-il éviter certaines activités ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Immunization+Programs&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Abcès épidural", "description": "Quel est le traitement principal ?\nLes antibiotiques sont-ils toujours nécessaires ?\nQuand faut-il envisager une intervention chirurgicale ?\nY a-t-il des traitements non chirurgicaux ?\nCombien de temps dure le traitement ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Immunization+Programs&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Abcès épidural", "description": "Quelles sont les complications possibles ?\nPeut-on avoir des séquelles après traitement ?\nComment la septicémie se développe-t-elle ?\nLes complications sont-elles fréquentes ?\nY a-t-il un risque de récidive ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Immunization+Programs&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Abcès épidural", "description": "Quels sont les principaux facteurs de risque ?\nLes diabétiques sont-ils plus à risque ?\nLe tabagisme influence-t-il le risque ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes antécédents d'abcès augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D020802?mesh_terms=Immunization+Programs&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un abcès épidural ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par IRM ou scanner, en plus des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire peuvent montrer une élévation des globules blancs et des marqueurs inflammatoires." } }, { "@type": "Question", "name": "Quels symptômes indiquent un abcès épidural ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs dorsales, fièvre, faiblesse, et parfois des troubles neurologiques." } }, { "@type": "Question", "name": "L'IRM est-elle toujours nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM est souvent recommandée, mais un scanner peut suffire dans certains cas." } }, { "@type": "Question", "name": "Peut-on diagnostiquer sans imagerie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic préliminaire peut être fait cliniquement, mais l'imagerie est cruciale." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur intense, fièvre, et parfois des troubles moteurs." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus subtils chez les personnes âgées." } }, { "@type": "Question", "name": "Y a-t-il des signes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des signes comme la faiblesse ou des engourdissements peuvent apparaître." } }, { "@type": "Question", "name": "Comment la douleur se manifeste-t-elle ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "La douleur est souvent localisée dans le dos et peut irradier vers les membres." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans fièvre ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent ne pas présenter de fièvre malgré un abcès." } }, { "@type": "Question", "name": "Comment prévenir un abcès épidural ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et traiter rapidement les infections cutanées." } }, { "@type": "Question", "name": "Les patients à risque doivent-ils être surveillés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients immunodéprimés ou ayant des antécédents d'infections doivent être surveillés." } }, { "@type": "Question", "name": "Les soins post-opératoires sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins appropriés après une chirurgie peuvent prévenir les infections." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent réduire le risque d'infections, mais pas spécifiquement d'abcès." } }, { "@type": "Question", "name": "Faut-il éviter certaines activités ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les activités à risque qui pourraient entraîner des infections est conseillé." } }, { "@type": "Question", "name": "Quel est le traitement principal ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la chirurgie pour drainer l'abcès, souvent suivi d'antibiotiques." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils toujours nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antibiotiques sont essentiels pour traiter l'infection sous-jacente." } }, { "@type": "Question", "name": "Quand faut-il envisager une intervention chirurgicale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention chirurgicale est nécessaire si l'abcès provoque des symptômes neurologiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements non chirurgicaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, un traitement médical peut être suffisant, mais c'est rare." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement dépend de la gravité, mais peut durer plusieurs semaines." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions nerveuses, une septicémie, et des douleurs chroniques." } }, { "@type": "Question", "name": "Peut-on avoir des séquelles après traitement ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles comme des douleurs chroniques ou des déficits neurologiques peuvent survenir." } }, { "@type": "Question", "name": "Comment la septicémie se développe-t-elle ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La septicémie peut se développer si l'infection se propage dans le sang, nécessitant une attention urgente." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent être graves, surtout si le traitement est retardé." } }, { "@type": "Question", "name": "Y a-t-il un risque de récidive ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de récidive existe, surtout si les facteurs de risque ne sont pas gérés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immunodépression, les infections cutanées, et les antécédents chirurgicaux." } }, { "@type": "Question", "name": "Les diabétiques sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients diabétiques ont un risque accru d'infections et d'abcès épiduraux." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affaiblir le système immunitaire et augmenter le risque d'infections." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les antécédents d'abcès augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents d'abcès épiduraux augmente le risque de récidive." } } ] } ] }

Sources (10000 au total)

Impact of the national hepatitis B immunization program in China: a modeling study.

Elimination of hepatitis B virus (HBV) is a striking challenge for countries with high or moderate disease burden. Therefore, using China as a practical case to share experiences for similar countries... We constructed an expanded Susceptible-Exposed-Infectious-Recovered (SEIR) model and decision tree-Markov model to estimate the epidemic of HBV in China, assess the feasibility of 2030 Elimination Goa... Between 1990 and 2020, the number of chronic HBV infections decreased by 33.9%. The current status quo would lead to 55.73 million infections (3.95% prevalence) in 2030, compared to 90.63 million (6.4... Our findings proved the HBV vaccination has demonstrated a substantial positive impact on controlling the epidemic of HBV in terms of effectiveness and economy after about 30 years of implementation o...

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new pre...

Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China.

Globally, rotavirus is a leading cause of severe acute gastroenteritis among children aged under 5 years and has a significant economic cost. Currently, rotavirus vaccines are only included in the pri... A decision tree Markov model was constructed to evaluate the cost-benefit of universal immunization with three doses of rotavirus vaccine for a 2019 birth cohort of Chinese children. Costs of the univ... For the 2019 birth cohort of Chinese infants, inclusion of RotaTeq in NIP was estimated to prevent 5,677,911 cases of rotavirus infection, with net savings of $1.1 billion in total societal costs. A c... Introducing rotavirus vaccine into the China NIP would have significant costs from a societal perspective at the current private market price....

Investigation of non-National Immunization Program vaccination intentions in rural areas of China.

China's current immunization program was revised in 2007. Some common childhood vaccines such as those for influenza, pediatric pneumonia, Haemophilus influenzae, varicella, and rotavirus have not bee... A qualitative method of in-depth interviews were conducted for this study. We interviewed 30 rural parents in a central Chinese village to investigate their awareness of non-NIP vaccines and their vac... This study summarized the individual and social level factors influencing the non-NIP vaccination intention of rural parents. The individual level factors include four themes: perceived severity with ... Based on these influencing factors, this study constructs a structural model for non-NIP vaccination decision-making process in rural areas of China. The results play a guiding role in directing atten...

Vaccination compliance of selected childhood immunization programs and the socio-determinant factors in Nigeria.

Adherence to full vaccination is important in preventing childhood diseases. The aim of this study was to evaluate the level of compliance to full vaccination and identify the socio-cultural factors a... The socioeconomic variables associated with each of the four binary dependent variables of whether or not a child is fully vaccinated against tetanus, BCG, measles, and pentavalent were determined usi... While compliance to full tetanus and BCG vaccinations was > 60% at the national level, less than 50% and 10% full vaccination compliance were recorded for pentavalent and measles vaccinations, respect... The socio-cultural factors associated with achieving full vaccination coverage in Nigeria in this study should drive the implementation of policies that will be best suited to each geopolitical zone o...

Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru.

This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a... A cost-minimization analysis compared the costs associated with vaccine administration, adverse reactions medical treatment, logistical activities, and indirect social costs associated with time spent... Incorporating the hexavalent vaccine would result in a 15.5% net increase in healthcare budget expenditure ($48,281,706 vs $55,744,653). Vaccination costs would increase by 54.1%, whereas logistical a... Despite of the significant reduction of logistical and adverse reaction costs, including the hexavalent vaccine into the National Immunization Program of Peru in place of the current vaccination schem...

Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs.

The COVID-19 pandemic represents a threat that has posed a challenge to public health response and threatens immunization programs globally. Despite recommendations to continue routine immunization se... We conducted a systematic literature review to identify studies globally that described how indicators of health system resilience, defined using the Resilient Health System Framework, enabled routine... Our study demonstrates the use of tools that contributed to immunization program resilience during the COVID-19 pandemic in all geographic regions and for countries with different income levels. These...